UNIGE document Scientific Article
previous document  unige:32505  next document
add to browser collection
Title

Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients

Authors
Scherer, Almut
Published in Annals of the Rheumatic Diseases. 2012, vol. 71, no. 6, p. 997-9
Abstract After inadequate response to an antitumour necrosis factor (aTNF) agent for treatment of rheumatoid arthritis (RA), rheumatologists can choose an alternative aTNF or a biological agent with another mode of action (non-aTNF biological (non-aTNF-Bio)).
Keywords AdultAgedAntibodies, Monoclonal, Humanized/administration & dosage/pharmacokineticsAntirheumatic Agents/administration & dosage/pharmacokineticsArthritis, Rheumatoid/drug therapyFemaleGlucocorticoids/administration & dosage/pharmacokineticsHumansImmunoconjugates/administration & dosage/pharmacokineticsIsoxazoles/administration & dosage/pharmacokineticsMaleMethotrexate/administration & dosage/pharmacokineticsMiddle AgedPrednisone/administration & dosage/pharmacokineticsProportional Hazards ModelsRegistriesRemission InductionTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitors
Identifiers
PMID: 22294628
Full text
Article (Published version) (119 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format)
MARTIN-DU-PAN, Sophie Marie Catherine et al. Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients. In: Annals of the Rheumatic Diseases, 2012, vol. 71, n° 6, p. 997-9. https://archive-ouverte.unige.ch/unige:32505

193 hits

0 download

Update

Deposited on : 2013-12-18

Export document
Format :
Citation style :